Tilray Brands reports record FY2026 revenue of $915.5M, adjusted EBITDA $61.1M, guides FY2027 EBITDA $68-75M

Tilray Brands, Inc.

FY2026 net revenue $915.5M (+11% YoY); adjusted EBITDA $61.1M; net loss $105.2M ($1.09 loss per share).
Q4 net revenue $281.7M (+25% YoY); adjusted EBITDA $31.9M; adjusted EPS $0.05.
FY2027 guidance: adjusted EBITDA $68M-$75M, double-digit growth.
International medical cannabis revenue up 34% in FY2026; cash & securities ~$235M; net debt $0.7M.
BrewDog acquisition expanded beverage platform; U.S. rescheduling evaluation ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.